Complexity of Gold(Ⅲ) Ion With Cefotaxime and Cefepime Drugs: Spectroscopic, Antimicrobial and Antitumor Discussions
Lamia A Albedair1*, Samar O Aljazzar1, Mohamed I Kobeasy2,3,Moamen S Refat3,4*
1. College of Science, Princess Nourah bint Abdulrahman University, Department of Chemistry, Saudi Arabia
2. Department of Biochemistry, Faculty of Agriculture, Cairo University, Giza, Egypt
3. Department of Chemistry, Faculty of Science, Taif University, Al-Hawiah, Taif 21974, Saudi Arabia
4. Department of Chemistry, Faculty of Science, Port Said University, Port Said, Egypt
Complexity of Gold(Ⅲ) Ion With Cefotaxime and Cefepime Drugs: Spectroscopic, Antimicrobial and Antitumor Discussions
Lamia A Albedair1*, Samar O Aljazzar1, Mohamed I Kobeasy2,3,Moamen S Refat3,4*
1. College of Science, Princess Nourah bint Abdulrahman University, Department of Chemistry, Saudi Arabia
2. Department of Biochemistry, Faculty of Agriculture, Cairo University, Giza, Egypt
3. Department of Chemistry, Faculty of Science, Taif University, Al-Hawiah, Taif 21974, Saudi Arabia
4. Department of Chemistry, Faculty of Science, Port Said University, Port Said, Egypt
摘要: The availability of chemical and biological data presented in this paper is the basis for understanding not only the current state of anti-cancer drugs based on gold(Ⅲ), but also the rationale for strategies for future drug design. New Au(Ⅲ) nanosized complexes of cefotaxime (ceph-3) and cefepime (ceph-4) ligands as a 3rd and 4th of cephalosporin generation drugs were synthesized. Gold(Ⅲ) complexes were discussed based on the elemental, molar conductance, thermal and magnetic moment measurements as well as spectral (FTIR, 1HNMR, UV-Vis, and XRD) techniques. FT-IR spectra revealed that the ceph-3 and ceph-4 ligands reacted as a bidentate ligands through carboxylate oxygen and β-lactam oxygen groups. The analytical analysis confirm that the molar ratio is 1∶1 (Au3+/ceph) with general formula [Au(L)(Cl)2] where L=ceph-3 or ceph-4. The structures of Au(Ⅲ) complexes were presence as a square planar geometry. X-ray diffraction patterns referred to a crystalline nature for all synthesized complexes. TEM analyses confirmed that the synthetic gold(Ⅲ) complexes have a nanosized particles. In vitro antimicrobial activities of Au(Ⅲ) complexes were evaluated towards two types of bacteria (G+ & G-). The antitumor activities of gold(Ⅲ) complexes are appraised against breast (MCF-7) and colorectal adenocarcinoma (Caco-2) cell lines, which means that the two complexes may consider promising anticancer drugs.
Abstract:The availability of chemical and biological data presented in this paper is the basis for understanding not only the current state of anti-cancer drugs based on gold(Ⅲ), but also the rationale for strategies for future drug design. New Au(Ⅲ) nanosized complexes of cefotaxime (ceph-3) and cefepime (ceph-4) ligands as a 3rd and 4th of cephalosporin generation drugs were synthesized. Gold(Ⅲ) complexes were discussed based on the elemental, molar conductance, thermal and magnetic moment measurements as well as spectral (FTIR, 1HNMR, UV-Vis, and XRD) techniques. FT-IR spectra revealed that the ceph-3 and ceph-4 ligands reacted as a bidentate ligands through carboxylate oxygen and β-lactam oxygen groups. The analytical analysis confirm that the molar ratio is 1∶1 (Au3+/ceph) with general formula [Au(L)(Cl)2] where L=ceph-3 or ceph-4. The structures of Au(Ⅲ) complexes were presence as a square planar geometry. X-ray diffraction patterns referred to a crystalline nature for all synthesized complexes. TEM analyses confirmed that the synthetic gold(Ⅲ) complexes have a nanosized particles. In vitro antimicrobial activities of Au(Ⅲ) complexes were evaluated towards two types of bacteria (G+ & G-). The antitumor activities of gold(Ⅲ) complexes are appraised against breast (MCF-7) and colorectal adenocarcinoma (Caco-2) cell lines, which means that the two complexes may consider promising anticancer drugs.
基金资助: the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, through the Research Funding Program (#RFP-1440-3)
通讯作者:
Lamia A Albedair,Moamen S Refat
E-mail: msrefat@yahoo.com
引用本文:
Lamia A Albedair, Samar O Aljazzar, Mohamed I Kobeasy,Moamen S Refat. Complexity of Gold(Ⅲ) Ion With Cefotaxime and Cefepime Drugs: Spectroscopic, Antimicrobial and Antitumor Discussions[J]. 光谱学与光谱分析, 2020, 40(10): 3315-3320.
Lamia A Albedair, Samar O Aljazzar, Mohamed I Kobeasy,Moamen S Refat. Complexity of Gold(Ⅲ) Ion With Cefotaxime and Cefepime Drugs: Spectroscopic, Antimicrobial and Antitumor Discussions. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2020, 40(10): 3315-3320.
[1] Parfitt K. “Martindale” The Complete Drug Reference. 33nd Edition. The Pharmaceutical Press, London, 2002. 167.
[2] Anacona J R, Rodriguez A. Trans. Met. Chem., 2005, 30: 897.
[3] Bergan T. Drugs, 1987, 34: 89.
[4] Ribeiro A R, Sures B, Schmidt T C. Environmental Pollution, 2018, 241: 1153.
[5] García-Estrada C, Martín J F. Comprehensive Biotechnology. Third Edition, Volume 3, 2019. 283.
[6] Sunjaya D B, Lennon R J, Shah V H, et al. Mayo Clinic Proceedings, 2019,94(8):1499.
[7] Anacona J R, Da Silva G. J. Chil. Chem. Soc., 2005, 50(2): 447.
[8] Okamoto M P, Nakahiro R K, Chin A, et al. Am. J. Hosp. Pharm., 1994,51(4):463.
[9] Barradell L B, Bryson H M. Drugs, 1994,47(3):471.
[10] Cunha B A, Gill M V. Med. Clin North Am., 1995, 79(4): 721.
[11] Chapman T M, Perry C M. Am. J. Respir Med., 2003, 2(1): 75.
[12] Anacona J R, Rodriguez H. J. Coord Chem., 2009, 62(13): 2212.
[13] Page S. Educ Chem., 2012, 10: 26.
[14] Farrell N. Drugs Chemother Agents., 1989, 11: 809.
[15] Ndagi U, Mhlongo N, Soliman M E. Drug. Des. Devel. Ther., 2017, 11: 599.
[16] Wheate N J, Walker S, Craig G E, et al. Dalton Trans., 2012, 39(35): 8113.
[17] El-Habeeb A A, Refat M S. J. Mol. Struct., 2019, 1175: 65.
[18] El-Megharbel S M, Hamza R Z, Gobouri A A, et al. Appl. Organomet. Chem., 2019,e4892:1.
[19] Naglah A M, Al-Omar M A, Kalmouch A, et al. Future Med. Chem., 2019,11(3):193.
[20] Naglah A M, Refat M S, AlOmar M A, et al. Drug Design, Development and Therapy, 2019,13:1409.
[21] El-Habeeb A A, Refat M S. Spectroscopy and Spectral Analysis, 2019,39(9):2982.
[22] Bauer A W, Kirby W A, Sherris C, et al. Am. J. Clin. Pathology, 1996,45:493.
[23] Pfaller M A, Burmeister L, Bartlett M A, et al. J. Clin. Microbiol., 1988,26:1437.
[24] Repetto G, del Peso A, Zurita J L. Nature Protocols, 2008, 3(7): 1125.
[25] Anaconaa J R, Rodriguez J R. J. Coord. Chem., 2004,57:1263.
[26] Anacona J R, Alvarez P. Trans. Met. Chem., 2002, 27: 856.
[27] Z Hong-Yum, C Dong-Li, C Pei-Kun, et al. Polyhedron, 1992,11:2313.
[28] Anacona J R, Da Silva G. J. Chil. Chem. Soc., 2005,50(2):447.
[29] Lever A B P. Inorganic Electronic Spectroscopy, 2nd ed. Amsterdam; New York: Elsevier; 1984. 863.
[30] Altun Ö, Şuözer M. JOTCSA., 2017, 4(sp. is. 1): 1.
[31] Patterson A L. Phys. Rev., 1939, 56: 978.
[32] Shungu D L. J. Clin. Microbiol., 1988, 18: 888.
[33] Shungu D L. Antimicrob. Agents Chemother, 1983, 23: 256.